chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, had no problems.  6 hours later was walking her dog and had light headedness and atrial fibrillation.  Then around 11:30 she started having flu-like symptoms, really bad headache, fever, her throat felt like it was closing off, achiness all over.  Then the fever continued to elevate through the night and could not get it under control, and it broke about 3:00 AM.  Around 9:00 fever came back, still flu-like symptoms, headache, head congestion and horrendous headache to the point that light hurt them, dizziness.  Just really bad congestion.  It continued to get worse as the days went on, and by Friday felt she had a sinus infection with bad congestion.  Went to the Hospital, did COVID test at home which were negative x2.  Felt she would go to the hospital for antibiotics for the sinus infection.  Her BP was running higher for her which typically was low.  She was exhausted, could not walk her dogs due to the exhaustion and had to sit down.  She has never lost her sense of taste or smell, problems with breathing, just the exhaustion.  In the hospital she had the COVID test and came back in and told her she was positive for COVID.  They also did one a sent it off.  They did a kidney test and gave her pamphlet, and had an oral option and a shot option.  She was supposed to get the antibody infusion yesterday.  She had her blood drawn and was ready to leave and the doctor came and told her to go to the hospital to make sure she did not have blood clots.  She did not go to the hospital for that check, picked up her dog and went home.  Her temperature kept increasing every night, it was up to 103, and felt bad.  By Sunday she convinced herself to go to the hospital, kidney test was fine.  She was exhausted, hard to get up to the bathroom.  Went to a different Hospital, and the 2nd COVID test came back negative that was sent off.   The doctor then told her that she had COVID again, and she told him to check the chart, and they did a chest x-ray which was clear and they gave her an antibiotic.  Was given a Z-Pak and nose spray and took some Zyrtec, and last night was the first time she did not have a fever of 103.  She feels better today, not 100% and felt that she was going into pneumonia.  States she will never take another vaccine.  She had not been around anybody, wears a mask and has to be careful as she is a caretaker for her elderly mother.   Her father died from COVID.    She normally walks 5 miles a day and was not able to do so.
Petechaie 24 hours after administration and lasting about a week. I can share a photo but I do not see a place to upload an image. Body aches, fever (102), extreme fatigue and lethargy, chills and shakes. Symptoms onset at 8 hours, resolved at 72 hours. My reaction to all the COVID vaccines have been quite intense.  Given the petechiae, I would like advise on whether or not I should get the Bivalent vaccine on December 9th as schedule.  I am a nurse and would like to get this booster.
Woke up with itching of left arm on 12/2/15, progressed to generalized itching and rash by the evening of 12/2. Went to ER, ER Dr thought maybe chicken Pox. Seen at office 12/3 with a maculo/papular rash most pronounce on left arm, but also seen on right arm, chest, face and ankles. Treated with Zyrtec and Pepcid. Itch gone by 12/5. Follow-up visit 12/7 back to baseline except faint pink marks remain.
abnormal menstrual bleeding, severe cramping, dizziness, nausea, diarrhea
Fatigue and lethargy; lethargy; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 25Apr2021 at 16:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 04Apr2021 at 13:15(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 27Apr2021 at 21:00, the patient experienced fatigue and lethargy. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event fatigue and lethargy was recovered on unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Felt weak; Felt herself "messed up"; Whole body pain; Can not move from the bad; Swelling in eyes; Swelling in hands; Headache; Fatigue/ Felt tired; Second dose was received on 10Mar2021 (on 36 day); Chills; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up") and PAIN (Whole body pain) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 10-Mar-2021 at 3:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (Chills). On 10-Mar-2021 at 3:00 PM, the patient experienced OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)). On 10-Mar-2021 at 6:00 PM, the patient experienced EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), HEADACHE (Headache) and FATIGUE (Fatigue/ Felt tired). On 11-Mar-2021, the patient experienced ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain) and MOVEMENT DISORDER (Can not move from the bad). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 10-Mar-2021 at 3:00 PM, OFF LABEL USE (Second dose was received on 10Mar2021 (on 36 day)) had resolved. At the time of the report, EYE SWELLING (Swelling in eyes), PERIPHERAL SWELLING (Swelling in hands), ASTHENIA (Felt weak), FEELING ABNORMAL (Felt herself "messed up"), PAIN (Whole body pain), MOVEMENT DISORDER (Can not move from the bad), HEADACHE (Headache), FATIGUE (Fatigue/ Felt tired) and CHILLS (Chills) outcome was unknown.            She treated symptoms also with ice bag topically on arm.
My heart beats weird, i feel like i?m having a constant anxiety attack, i can?t eat much. my jaw hurts sometimes, same with ears i feel like i have an ear infection
Hospitalization; it has been more than 90 days; This spontaneous case was reported by a pharmacist and describes the occurrence of HOSPITALISATION (Hospitalization) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HOSPITALISATION (Hospitalization) (seriousness criterion hospitalization) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it has been more than 90 days). At the time of the report, HOSPITALISATION (Hospitalization) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (it has been more than 90 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was provided.  Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Fatigue, chills, site is red and slightly itchy - can feel raised area where it was given
Patient reported she felt tired when she got home 5 hours after vaccination. She also reported feeling "hot" but had no fever 9 hours later and 11 hours later had a temperature 100.8F and 102F was the highest temperature. She also reported body aches and arm soreness and elevated heart rate with the highest noted rate at 119 bpm. She also reported chills and also feeling hot. She also reported eye swelling but has history of severe dry eye and has had this symptom before. Today she reported only soreness to her arm. On examination her injection site appears to have a small bruise with no redness, swelling or heat noted.
Woke up, difficullty breathing, asthma attack... used Xopenex HFA inhaler, drank coffee, walked around a lot...
Slight headache; Right arm was sore where shot was; Little tiredness; Arm swelling after first dose; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 17Mar2021 10:15 (Batch/Lot Number: EN6198) at the age of 47-years-old as single dose for covid-19 immunization (reported as 'protection for self and others').  Medical history included ongoing Fibroneuropathy, he had it in his feet, started after low back surgery 30 years before in 1991, L5 fractured, had 2 rods and 4 screws into low back, ongoing tremors both arms and hands, mainly left started in high school when first he first noticed, ongoing high blood pressure started in early 2000s, ongoing high cholesterol started in early 2000s, and patient had been on social security disability since 2014 and ongoing. The patient's concomitant medications were not reported. The patient experienced slight headache, right arm was sore where shot was, little tiredness, arm swelling after first dose on 17Mar2021. The outcome of the event headache was recovered on 17Mar2021 with duration of 15 minutes, the outcome of the other events was recovered on 19Mar2021.  No follow-up attempts are needed. No further information is expected.
Left Arm Pain; arm is still sore and underneath it is like spasming/someone was punching and punching her; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Apr2021 (Lot number: ER8737) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "thyroid" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for thyroid disorder. Vaccination history included: Measles vaccine (as a kid, she had the German Measles vaccine and then after that she got the German Measles.), for Immunisation, reaction(s): "German Measles". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 01Apr2021, outcome "recovered" (04Apr2021), described as "Left Arm Pain; arm is still sore and underneath it is like spasming/someone was punching and punching her".  Additional information: Caller stated that she had her first shot in her right arm, and it was sore, but it went away after 3 days. Prior Vaccinations (within 4 weeks): Patient had received both doses of the Pfizer Covid Vaccine.  No follow-up attempts are possible. No further information is expected.
pt recv vax 30NOV94 & exp  fever of 105 & convuls 1DEC94 mid morning around 10AM;
This spontaneous report was received from a registered nurse regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored PNEUMOVAX 23 Prefilled syringes lot # L019835/expiration date- 23-MAY-2017 (incorrect product storage). No adverse event. Excursion temperature was 31 F and timeframe was 152 days (worst case). There was no prior temperature excursion. Call was because of the data logger. No concomitant medication was reported. The outcome of the event was unknown. No PQC (product quality complaint) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaixs. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of hep B vaccine on 1/9/95 and 2/8/95. He received an injection of Engerix B on 9/28/95 (lot 1513B2). He also received injections of Tetramune 2/8/95, 4/13/95 and 6/21/95, DTP 4/4/96, Hib-Titer 4/4/96, and DT 8/11/00. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received, he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
This patient had redness, tender to the touch, swelling for one week, largest area at approximately 75 mm x 75 mm.
1. Postimmunization reaction, initial encounter Patient is a 30-year-old female who presented with swelling and pain of her right shoulder following a Tdap injection. She describes the pain diffusely shoulder and has pain lifting her arm above her head. She also describes some pain in her elbow. She does have a small bruise although I do not see any significant swelling or erythema she does have good range of motion although she is somewhat tender. It appears she is out postimmunization reaction I will give her a Medrol Dosepak and have her follow-up if she is not rapidly improving. Plan: 1. Others Start Medrol Tablet Therapy Pack, 4 MG, as directed, Orally, Once a day, 5 days, 1 Each, Refills 0 .
Large bruising from right under site of administration down arm approx. 1 inch above elbow. Bruise began 10/7/16 and is still present as of today 10/19/16.
Sore at injection site; Bloody nose; Diarrhea; Fatigue; This is a spontaneous report from a non-contactable consumer (patient).  This 44-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EM9810), via an unknown route, on 02Feb2021 11:30 (at the age of 44-year-old) as single dose for COVID-19 immunisation, administered at hospital. No other vaccine was received in four weeks. Pre-vaccination and post-vaccination COVID tests were not performed. The patient did not have a relevant medical history and concomitant medications. On 03Feb2021 at 10:00, the patient developed sore at injection site, bloody nose, diarrhea, and fatigue. The patient was not treated for the events. The patient had recovered from the events on unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous  report as received from a nursing student refers to one of her unspecified relatives,  a female patient of unknown age. On an unknown date the patient was vaccinated with the third dose of GARDASIL injection (dose, route, lot # and expiry date unknown). The patient was sick to her stomach and had thrown up four days later after receiving her third dose of GARDASIL on an unspecified date. The nursing student also noted that this unspecified relative also shortly before had a milkshake before this adverse event occurred. The outcome of the events was unknown. Additional information has been requested.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 13-JAN-2017 at 15:44, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
After receiving the shot the pt got light headed and almost fainted called 911, and the paramedics came and took pt to hospital. The pt blood pressure was 77/44. The pt had fasted for a blood test earlier in the morning , and stated to the paramedics that he had felt light headed before the shot. but the pt had not mentioned it before the shot
Information has been received from a physician concerning a 15 year old patient who on 14-JAN-2009 was vaccinated with the first dose of GARDASIL.  Subsequently the patient experienced significant swelling of the upper arm.  Approximately a six inch region of the upper arm swelled to double the normal size following the administration of the vaccine.  The patient was tested and the physician found significantly elevated level of immunoglobulin E (IGE).  Additional information has been requested.
Information has been received from the authors of the published literature article. To describe the case of a devastating multiple sclerosis (MS) relapse that occurred after fingolimod cessation and worsened dramatically after administration of the live varicella virus vaccine (VAR) (manufacturer unknown). A 39-year-old woman with longstanding MS presented for initial evaluation in October 2015, with gait disturbance. Her prior neurologist stopped fingolimod 4 months prior and started glatiramer acetate. She had been on fingolimod for 3 years before it was discontinued and had been clinically, but not radiographically stable. She was admitted to hospital for rescue apheresis. Magnetic resonance imaging (MRI) brain showed diffuse gadolinium enhancement. Her gait improved after apheresis, and the plan was to change MS therapy to alemtuzumab. She had no titer to varicella virus, and so was vaccinated with VAR (manufacturer unknown) at discharge with plan to start alemtuzumab 8 weeks later. She was readmitted two weeks later with clinical worsening. Examination revealed quadraparesis and decreased level of consciousness. MRIs of brain and spine revealed multiple new lesions with diffuse gadolinium enhancement. Cerebrospinal fluid (CSF) had 20 white blood cell (WBC) (86% lymphocytes) and a negative varicella zoster virus (VZV) polymerase chain reaction (PCR). A full infectious work-up was negative. She worsened clinically over the next 6 weeks with repeat MRIs showing multiple new enhancing lesions typical of MS. Rescue therapy included repeat courses of IV solumedrol, apheresis, and IV cyclophosphamide, none of which stabilized her. By 11-DEC-2015 she was quadriplegic. She was then treated with high dose IV methotrexate with leukovorin rescue. On 29-DEC-2015, MRI of the brain finally showed resolution of enhancement, and she stabilized clinically. Rituximab was administered as new long-term immunotherapy. She was transferred to long-term acute care hospital with a feeding tube and tracheostomy. The patient had significant reactivation of MS after cessation of fingolimod, a phenomenon well-described in the literature, and she responded at first in a typical fashion to rescue apheresis. We believe that this garden-variety relapse was transformed into a devastating exacerbation by the VAR (manufacturer unknown). Varicella is a neurotropic virus that has been associated with MS exacerbations. The severity of this exacerbation worsened dramatically after vaccination and resulted in significant permanent disability. Upon internal review Multiple Sclerosis was considered to be a serious event due to medically significant.A copy of the published literature article is attached as further documentation of the patient's experience. Additional information has been requested.